-- 
Israeli Stocks: Dexia, Isras, I.T.G.I., Kamada, Lifewave, Sialo

-- B y   R o n i t   G o o d m a n
-- 
2011-04-10T14:53:41Z

-- http://www.bloomberg.com/news/2011-04-10/israeli-stocks-dexia-isras-i-t-g-i-kamada-lifewave-sialo.html
Israel ’s TA-25 Index advanced the
most in two weeks, gaining 1 percent to 1,330.54 at the 4:30
p.m. close in Tel Aviv. Investors traded about 972.2 million
shekels ($283 million) in shares and convertible securities.  The following stocks rose or fell today. Symbols are in
parentheses.  Dexia Israel Bank Ltd. (DXIL IT) jumped 5 percent to 682.50
shekels, the highest level since at least 1995 when Bloomberg
began tracking the shares. Dexia SA said it received and is
considering several offers for its holdings in the lender.  Isras Investment Company Ltd. (ISRS IT) rose to the highest
since January 2008, increasing 7 percent to 139.10 shekels. The
building company’s board approved the acquisition of OCIF
Investments and Development Ltd. (OCIF IT). OCIF fell 1.5
percent to 17.46 shekels.  I.T.G.I. Medical Ltd. (ITGI IT) climbed to the highest
since Feb. 27, gaining 5.9 percent to 0.448 shekel. The maker of
vascular products said its pericardium covered stent won
international recognition in a cardiovascular magazine.  Kamada Ltd. (KMDA)   advanced the most in more than two
months, adding 4.5 percent to 31.61 shekels. The
biopharmaceutical company received a U.S. patent for use of
alpha 1 antitrypsin to treat exacerbation episodes of pulmonary
diseases.  Lifewave Ltd. (LIFE)   dropped to the lowest since January
2009, losing 3.9 percent to 1.904 shekels. The maker of medical
equipment raised 2.2 million shekels from a share sale.  Sialo Technology Israel Ltd. (SALO)   increased the most
since Jan. 9, climbing 5.4 percent to 1.383 shekels. The
developer of surgical equipment signed an agreement with A.D.C.
Co. Israel Ltd. to exclusively distribute the company’s dental
systems in Russia, Ukraine and  Kazakhstan .  To contact the reporter on this story:
Ronit Goodman in  Tel Aviv  at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  